You can buy or sell Mylan and other stocks, options, ETFs, and crypto commission-free!
Mylan N.V. Ordinary Shares, also called Mylan, is a pharmaceutical healthcare company. Read More The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
52 Week High
52 Week Low
Mylan offers concessions to address EU concerns about Pfizer deal
FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 29, 2019. REUTERS/Brendan McD
BRIEF-S. Africa's Competition Commission Conditionally Approves Proposed Merger Whereby UpJohn Intends To Acquire Mylan
March 27 (Reuters) - Mylan NV: * S. AFRICA’S COMPETITION COMMISSION - COMMISSION HAS CONDITIONALLY APPROVED PROPOSED MERGER WHEREBY UPJOHN INC. (NEWCO) INTENDS
— per share
Expected May 7, After Hours
UPDATE 1-Mylan waives exclusive U.S. distribution rights for potential COVID-19 therapy
(Adds details from Mylan statement, background) March 25 (Reuters) - U.S. drugmaker Mylan NV said on Wednesday it had waived its exclusive U.S. distribution ri